Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
JAMA, 318(15), 1460-1470
This is annoying but recoverable
We teach you exactly how at your visit
The 30-Second Verdict I pulled the head-to-head Phase 3 data, the SURMOUNT-5 NEJM paper, and the December 2025 TRIUMPH-4 topline readout side by side
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial
The cost difference is enormous (brand-name can exceed $1,000 per month without insurance), but so is the dosing safety margin
US$ 25.00
US$ 25.56
US$ 20.33
US$ 21.21
![Growth Spiral (Surge Foil) [Doctor Who] Shadows over Innistrad Promos](https://cdn.shopify.com/s/files/1/0304/5520/1930/files/0280e873-528d-5f06-ba98-ea67711a4b67.png?v=1768511273)
